| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2068 | 2017 |
| Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts H Joensuu, A Vehtari, J Riihimäki, T Nishida, SE Steigen, P Brabec, ... The lancet oncology 13 (3), 265-274, 2012 | 1045 | 2012 |
| Large-scale whole-genome sequencing of the Icelandic population DF Gudbjartsson, H Helgason, SA Gudjonsson, F Zink, A Oddson, ... Nature genetics 47 (5), 435-444, 2015 | 833 | 2015 |
| Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly F Zink, SN Stacey, GL Norddahl, ML Frigge, OT Magnusson, I Jonsdottir, ... Blood, The Journal of the American Society of Hematology 130 (6), 742-752, 2017 | 688 | 2017 |
| A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes S Thorlacius, G Olafsdottir, L Tryggvadottir, S Neuhausen, JG Jonasson, ... Nature genetics 13 (1), 117-119, 1996 | 659 | 1996 |
| Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study G Gatta, L Botta, MJ Sánchez, LA Anderson, D Pierannunzio, L Licitra, ... European journal of cancer 51 (15), 2130-2143, 2015 | 514 | 2015 |
| Gastrointestinal stromal tumors in Iceland, 1990–2003: The Icelandic GIST study, a population‐based incidence and pathologic risk stratification study G Tryggvason, HG Gíslason, MK Magnússon, JG Jónasson International journal of cancer 117 (2), 289-293, 2005 | 491 | 2005 |
| Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study G Gatta, R Capocaccia, L Botta, S Mallone, R De Angelis, E Ardanaz, ... The Lancet Oncology 18 (8), 1022-1039, 2017 | 483 | 2017 |
| Common variants on 9q22. 33 and 14q13. 3 predispose to thyroid cancer in European populations J Gudmundsson, P Sulem, DF Gudbjartsson, JG Jonasson, A Sigurdsson, ... Nature genetics 41 (4), 460-464, 2009 | 471 | 2009 |
| Mutations in BRIP1 confer high risk of ovarian cancer T Rafnar, DF Gudbjartsson, P Sulem, A Jonasdottir, A Sigurdsson, ... Nature genetics 43 (11), 1104-1107, 2011 | 438 | 2011 |
| Study of a single BRCA2 mutation with high carrier frequency in a small population. S Thorlacius, S Sigurdsson, H Bjarnadottir, G Olafsdottir, JG Jonasson, ... American journal of human genetics 60 (5), 1079, 1997 | 398 | 1997 |
| Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries SC Chuang, G Scelo, JM Tonita, S Tamaro, JG Jonasson, EV Kliewer, ... International journal of cancer 123 (10), 2390-2396, 2008 | 350 | 2008 |
| The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study TT Agustsson, T Baldvinsdottir, JG Jonasson, E Olafsdottir, ... European Journal of Endocrinology 173 (5), 655-664, 2015 | 332 | 2015 |
| Survival of women with cancers of breast and genital organs in Europe 1999–2007: results of the EUROCARE-5 study M Sant, MDC Lopez, R Agresti, MJS Pérez, B Holleczek, ... European journal of cancer 51 (15), 2191-2205, 2015 | 329 | 2015 |
| Epigenetic silencing and deletion of the BRCA1gene in sporadic breast cancer V Birgisdottir, OA Stefansson, SK Bodvarsdottir, H Hilmarsdottir, ... Breast cancer research 8, 1-10, 2006 | 320 | 2006 |
| Risk of breast cancer in female flight attendants: a population-based study (Iceland) V Rafnsson, H Tulinius, JG Jónasson, J Hrafnkelsson Cancer Causes & Control 12, 95-101, 2001 | 319 | 2001 |
| A germline variant in the TP53 polyadenylation signal confers cancer susceptibility SN Stacey, P Sulem, A Jonasdottir, G Masson, J Gudmundsson, ... Nature genetics 43 (11), 1098-1103, 2011 | 313 | 2011 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 297 | 2022 |
| Risk of second cancer among women with breast cancer L Mellemkjær, S Friis, JH Olsen, G Scélo, K Hemminki, E Tracey, ... International journal of cancer 118 (9), 2285-2292, 2006 | 280 | 2006 |
| Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits U Styrkarsdottir, G Thorleifsson, P Sulem, DF Gudbjartsson, A Sigurdsson, ... Nature 497 (7450), 517-520, 2013 | 279 | 2013 |
